Literature DB >> 23728003

How to find a prognostic biomarker for progressive diabetic nephropathy.

Frank C Brosius1, Subramaniam Pennathur.   

Abstract

As a prognostic biomarker for progression of diabetic nephropathy, albuminuria fails in terms of sensitivity and specificity. Better urinary or plasma biomarkers are needed that can predict which diabetic patients are at highest risk for progression. Bhensdadia et al. report proteomic investigations that identified urinary haptoglobin as a potential prognostic biomarker for progressive diabetic nephropathy. Although as a single marker urinary haptoglobin adds little to albuminuria, together the two appear to provide better diagnostic accuracy than albuminuria alone.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23728003      PMCID： PMC3994989          DOI： 10.1038/ki.2013.58

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  12 in total

1.  Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy.

Authors:  Hasan H Otu; Handan Can; Dimitrios Spentzos; Robert G Nelson; Robert L Hanson; Helen C Looker; William C Knowler; Manuel Monroy; Towia A Libermann; S Ananth Karumanchi; Ravi Thadhani
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

2.  Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

Authors:  Tomohito Gohda; Monika A Niewczas; Linda H Ficociello; William H Walker; Jan Skupien; Florencia Rosetti; Xavier Cullere; Amanda C Johnson; Gordon Crabtree; Adam M Smiles; Tanya N Mayadas; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

3.  Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

Authors:  Monika A Niewczas; Tomohito Gohda; Jan Skupien; Adam M Smiles; William H Walker; Florencia Rosetti; Xavier Cullere; John H Eckfeldt; Alessandro Doria; Tanya N Mayadas; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

4.  Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo.

Authors:  Rabea Asleh; Julia Guetta; Shiri Kalet-Litman; Rachel Miller-Lotan; Andrew P Levy
Journal:  Circ Res       Date:  2005-01-20       Impact factor: 17.367

5.  Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.

Authors:  Bruce A Perkins; Linda H Ficociello; Betsy E Ostrander; Kristen H Silva; Janice Weinberg; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2007-02-28       Impact factor: 10.121

6.  Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.

Authors:  R Nosadini; M Velussi; E Brocco; M Bruseghin; C Abaterusso; A Saller; M Dalla Vestra; A Carraro; E Bortoloso; M Sambataro; I Barzon; F Frigato; B Muollo; M Chiesura-Corona; G Pacini; B Baggio; F Piarulli; A Sfriso; P Fioretto
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

7.  Urinary proteomics in diabetes and CKD.

Authors:  Kasper Rossing; Harald Mischak; Mohammed Dakna; Petra Zürbig; Jan Novak; Bruce A Julian; David M Good; Joshua J Coon; Lise Tarnow; Peter Rossing
Journal:  J Am Soc Nephrol       Date:  2008-04-30       Impact factor: 10.121

8.  Transcriptome analysis of human diabetic kidney disease.

Authors:  Karolina I Woroniecka; Ae Seo Deok Park; Davoud Mohtat; David B Thomas; James M Pullman; Katalin Susztak
Journal:  Diabetes       Date:  2011-07-13       Impact factor: 9.461

9.  Haptoglobin genotype and renal function decline in type 1 diabetes.

Authors:  Tina Costacou; Robert E Ferrell; Demetrius Ellis; Trevor J Orchard
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

10.  Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.

Authors:  Nishant M Bhensdadia; Kelly J Hunt; Maria F Lopes-Virella; J Michael Tucker; Mohammad R Mataria; Joseph L Alge; Benjamin A Neely; Michael G Janech; John M Arthur
Journal:  Kidney Int       Date:  2013-03-27       Impact factor: 10.612
View more
  6 in total

1.  The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol.

Authors:  Hao-Han Chang; Bernard Choong; Anthony R J Phillips; Kerry M Loomes
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-24

2.  Nonblood/urine biomarker of progression of kidney disease in diabetes mellitus.

Authors:  Ramin Tolouian; Aaron I Vinik
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-19       Impact factor: 8.237

3.  Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes.

Authors:  Sridevi Gutta; Nadja Grobe; Meenasri Kumbaji; Hassan Osman; Mohammad Saklayen; Gengxin Li; Khalid M Elased
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-21

4.  Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.

Authors:  Chi-Yuan Hsu; Dawei Xie; Sushrut S Waikar; Joseph V Bonventre; Xiaoming Zhang; Venkata Sabbisetti; Theodore E Mifflin; Josef Coresh; Clarissa J Diamantidis; Jiang He; Claudia M Lora; Edgar R Miller; Robert G Nelson; Akinlolu O Ojo; Mahboob Rahman; Jeffrey R Schelling; Francis P Wilson; Paul L Kimmel; Harold I Feldman; Ramachandran S Vasan; Kathleen D Liu
Journal:  Kidney Int       Date:  2016-10-28       Impact factor: 10.612

5.  Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.

Authors:  Stephen Zewinger; Thomas Rauen; Michael Rudnicki; Giuseppina Federico; Martina Wagner; Sarah Triem; Stefan J Schunk; Ioannis Petrakis; David Schmit; Stefan Wagenpfeil; Gunnar H Heine; Gert Mayer; Jürgen Floege; Danilo Fliser; Hermann-Josef Gröne; Thimoteus Speer
Journal:  J Am Soc Nephrol       Date:  2018-10-02       Impact factor: 10.121

6.  Loss of prolyl carboxypeptidase in two-kidney, one-clip goldblatt hypertensive mice.

Authors:  Nadja Grobe; Orly Leiva; Mariana Morris; Khalid M Elased
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.